chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia, Sleep disorder
Clinical narrative: Restless sleep; I was nauseous; No energy; Dry cough; Had a temperature the day after the shot 99.8.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 01), for COVID-19 Immunization; Bnt162b2 (Dose: 02), for COVID-19 Immunization. The following information was reported: NAUSEA (non-serious), outcome "recovered", described as "I was nauseous"; ASTHENIA (non-serious), outcome "recovered", described as "No energy"; COUGH (non-serious), outcome "recovered", described as "Dry cough"; PYREXIA (non-serious), outcome "recovered", described as "Had a temperature the day after the shot 99.8."; SLEEP DISORDER (non-serious), outcome "recovered", described as "Restless sleep". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient have had a bad week after this 3rd shot. Patient was nauseous. No energy restless sleep. Had a temperature the day after the shot 99.8. Normal temperature is 97.4. It had been a week now, also a dry cough if patient did not drink enough and slightly raised temperature. Today 7 days gone patient felt pretty well, sugar level in normal limits.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia, Vaccination site pain
Clinical narrative: fever; chills; fatigue; injection site soreness; Body aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Oct2021 15:00 (Lot number: FF8841) at the age of 52 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing). Concomitant medication(s) included: AMBIEN taken for sleep disorder (ongoing); TYLENOL. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6199, Location of injection: Arm Left, Vaccine Administration Time: 03:00 PM), administration date: 30Mar2021, when the patient was 52 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3248, Location of injection: Arm Left, Vaccine Administration Time: 02:00 PM), administration date: 09Mar2021, for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 21Oct2021 11:00, outcome "recovered" (22Oct2021), described as "fever"; CHILLS (non-serious) with onset 21Oct2021 11:00, outcome "recovered" (22Oct2021), described as "chills"; FATIGUE (non-serious) with onset 21Oct2021 11:00, outcome "recovered" (Oct2021), described as "fatigue"; VACCINATION SITE PAIN (non-serious) with onset 21Oct2021 11:00, outcome "recovered" (Oct2021), described as "injection site soreness"; PAIN (non-serious) with onset 21Oct2021 11:00, outcome "recovered" (22Oct2021), described as "Body aches". Therapeutic measures were taken as a result of pyrexia, chills, pain. Therapeutic measures were not taken as a result of fatigue, vaccination site pain.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination.Facility where the most recent COVID-19 vaccine was administered: Workplace clinic.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Flushing
Clinical narrative: flushing; light headed; felt really spacy for like 2 hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 70 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 14Feb2021 09:00 (Lot number: EN6201) at the age of 70 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Factor 5 Leiden" (unspecified if ongoing). There were no concomitant medications. The following information was reported: FLUSHING (non-serious) with onset 14Feb2021, outcome "recovered" (14Feb2021), described as "flushing"; DIZZINESS (non-serious) with onset 14Feb2021, outcome "recovered" (14Feb2021), described as "light headed"; FEELING ABNORMAL (non-serious) with onset 14Feb2021, outcome "recovered" (14Feb2021), described as "felt really spacy for like 2 hours".  Additional information: After the first dose, in 5 minutes, she had flushing, was light headed, and felt really spacy for like 2 hours. It went away. No additional vaccines administered on same date of the Pfizer suspect. The patient had no prior Vaccinations (within 4 weeks).  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash macular
Clinical narrative: having itching on her back and on her chest; a spot on her arm that appeared at the same time with the rash; a spot on her arm that appeared at the same time with the rash; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 65 year-old female patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose:01), for COVID-19 Immunization. The following information was reported: PRURITUS (non-serious) with onset 2021, outcome "unknown", described as "having itching on her back and on her chest"; CONTUSION (non-serious), RASH (non-serious) all with onset 2021, outcome "unknown" and all described as "a spot on her arm that appeared at the same time with the rash".  Additional information: Patient called to report an adverse event 4 weeks after receiving her 2nd dose of the Covid19 Vaccine. Patient reported that there was a spot that looks like an "old person's bruise" as she described, but it doesn't felt like a bruise, patient mentioned it was small, oval-shaped but it's not painful. Patient stated that she had itching that she never had before on her back and frontside chest that started a week ago and is not as bad as it was. She also developed a spot on her arm that looks like a old person bruise on her right arm. It appeared about the same time as the itching. She said that it does not feel like a bruise and she was concerned.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Erythema, Fatigue, Joint range of motion decreased, Muscular weakness
Clinical narrative: General Fatigue; Limited mobility of right arm, unable to lift arm to normal heights; unable to lift arm to normal heights; pain at injection site; redness and swelling of right hand; redness and swelling of right hand; weakness in right hand including weakened grip; sluggish mobility; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 25 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 21Oct2021 14:30 (Lot number: FF8841) at the age of 25 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: other medical history: Asthma; "COVID-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes; "Allergy" (unspecified if ongoing), notes: Relevant past drug history:, Name of Drug as Reported: No, Reaction: Allergy. Concomitant medication(s) included: BENADRYL; CLARITINE; ALBUTEROL HFA. The following information was reported: FATIGUE (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "General Fatigue"; JOINT RANGE OF MOTION DECREASED (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "Limited mobility of right arm, unable to lift arm to normal heights"; AXILLARY PAIN (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "unable to lift arm to normal heights"; VACCINATION SITE PAIN (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "pain at injection site"; ERYTHEMA (non-serious), PERIPHERAL SWELLING (non-serious) all with onset 21Oct2021 14:30, outcome "not recovered" and all described as "redness and swelling of right hand"; MUSCULAR WEAKNESS (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "weakness in right hand including weakened grip"; SLUGGISHNESS (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "sluggish mobility". Therapeutic measures were not taken as a result of fatigue, joint range of motion decreased, axillary pain, vaccination site pain, erythema, peripheral swelling, muscular weakness, sluggishness.  Additional Information: The patient administered CaOVID-19 vaccine at Facility: Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Albuterol inhaler as a medication within 2 weeks of vaccination. Prior to vaccination, the patient was diagnosed with COVID. Since the vaccination, the patient has not been tested for COVID-19.  Follow-up (27Oct2021): Follow-up attempts are completed. No further information is expected.  No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Sluggishness, Vaccination site pain
Clinical narrative: General Fatigue; Limited mobility of right arm, unable to lift arm to normal heights; unable to lift arm to normal heights; pain at injection site; redness and swelling of right hand; redness and swelling of right hand; weakness in right hand including weakened grip; sluggish mobility; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 25 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 21Oct2021 14:30 (Lot number: FF8841) at the age of 25 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: other medical history: Asthma; "COVID-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes; "Allergy" (unspecified if ongoing), notes: Relevant past drug history:, Name of Drug as Reported: No, Reaction: Allergy. Concomitant medication(s) included: BENADRYL; CLARITINE; ALBUTEROL HFA. The following information was reported: FATIGUE (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "General Fatigue"; JOINT RANGE OF MOTION DECREASED (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "Limited mobility of right arm, unable to lift arm to normal heights"; AXILLARY PAIN (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "unable to lift arm to normal heights"; VACCINATION SITE PAIN (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "pain at injection site"; ERYTHEMA (non-serious), PERIPHERAL SWELLING (non-serious) all with onset 21Oct2021 14:30, outcome "not recovered" and all described as "redness and swelling of right hand"; MUSCULAR WEAKNESS (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "weakness in right hand including weakened grip"; SLUGGISHNESS (non-serious) with onset 21Oct2021 14:30, outcome "not recovered", described as "sluggish mobility". Therapeutic measures were not taken as a result of fatigue, joint range of motion decreased, axillary pain, vaccination site pain, erythema, peripheral swelling, muscular weakness, sluggishness.  Additional Information: The patient administered CaOVID-19 vaccine at Facility: Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Albuterol inhaler as a medication within 2 weeks of vaccination. Prior to vaccination, the patient was diagnosed with COVID. Since the vaccination, the patient has not been tested for COVID-19.  Follow-up (27Oct2021): Follow-up attempts are completed. No further information is expected.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Hypersensitivity, Nasopharyngitis, Pyrexia
Clinical narrative: colds or allergies; colds or allergies; runny nose; fever; loss of taste and smell; loss of taste and smell; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: Nasopharyngitis (non-serious), Hypersensitivity (non-serious) all with onset Oct2021, outcome "unknown" and all described as "colds or allergies"; Rhinorrhea (non-serious) with onset Oct2021, outcome "unknown", described as "runny nose"; Pyrexia(non-serious) with onset Oct2021, outcome "unknown", described as "fever"; Ageusia (non-serious), Anosmia(non-serious) all with onset Oct2021, outcome "unknown" and all described as "loss of taste and smell".  Additional information: It was reported that Caller had the 1st dose of the vaccine 3 weeks ago. A week after she got the vaccine, she thought that she had colds or allergies. She had runny nose, fever, loss of taste and smell and it is slowly returning now, and stuffy. Caller would like to know if this is colds, Covid or a reaction of the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: colds or allergies; colds or allergies; runny nose; fever; loss of taste and smell; loss of taste and smell; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: Nasopharyngitis (non-serious), Hypersensitivity (non-serious) all with onset Oct2021, outcome "unknown" and all described as "colds or allergies"; Rhinorrhea (non-serious) with onset Oct2021, outcome "unknown", described as "runny nose"; Pyrexia(non-serious) with onset Oct2021, outcome "unknown", described as "fever"; Ageusia (non-serious), Anosmia(non-serious) all with onset Oct2021, outcome "unknown" and all described as "loss of taste and smell".  Additional information: It was reported that Caller had the 1st dose of the vaccine 3 weeks ago. A week after she got the vaccine, she thought that she had colds or allergies. She had runny nose, fever, loss of taste and smell and it is slowly returning now, and stuffy. Caller would like to know if this is colds, Covid or a reaction of the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Rash
Clinical narrative: Patient pregnant, last menstrual date: 13May2021, administration date: 22Oct2021; Rash all over face,arms,and chest.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 22 year-old female patient (pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Oct2021 11:30 (Lot number: FH8027) at the age of 22 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Date of last menstrual period: 13May2021. The patient was 23 weeks pregnant at the time of exposure to bnt162b2. The patient was 23 weeks pregnant at the event onset. The patient is expected to deliver a baby(s) on 17Feb2022. Concomitant medication(s) included: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Ff2587, Location of injection: Arm Left, Vaccine Administration Time: 11:30), administration date: 01Oct2021, when the patient was 22 years old, for Covid-19 immunization. The following information was reported: MATERNAL EXPOSURE DURING PREGNANCY (non-serious), outcome "unknown", described as "Patient pregnant, last menstrual date: 13May2021, administration date: 22Oct2021"; RASH (non-serious) with onset 22Oct2021 13:00, outcome "recovering", described as "Rash all over face,arms,and chest.". Therapeutic measures were not taken as a result of rash.  Additional information: The patient had past drug history included: (unspecified) drug name and reaction(s): "Allergy".
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: cold symptoms; sore arm; sneezing; runny nose; cough; headache; low energy; extreme fatigue; easily out of breath; vision problems; brain fog; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Aug2021 11:00 (Lot number: FA7485) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypothyroid" (unspecified if ongoing), notes: Hypothyroid. Concomitant medication(s) included: NP THYROID; VITAMIN C [ASCORBIC ACID]; VITAMIN D3; VITAMIN B12 [CYANOCOBALAMIN]; MAGNESIUM; TURMERIC [CURCUMA LONGA]. The following information was reported: NASOPHARYNGITIS (non-serious) with onset Aug2021, outcome "unknown", described as "cold symptoms"; PAIN IN EXTREMITY (non-serious) with onset Aug2021, outcome "unknown", described as "sore arm"; SNEEZING (non-serious) with onset Aug2021, outcome "unknown", described as "sneezing"; RHINORRHOEA (non-serious) with onset Aug2021, outcome "unknown", described as "runny nose"; COUGH (non-serious) with onset Aug2021, outcome "unknown", described as "cough"; HEADACHE (non-serious) with onset Aug2021, outcome "unknown", described as "headache"; ASTHENIA (non-serious) with onset Aug2021, outcome "unknown", described as "low energy"; FATIGUE (non-serious) with onset Aug2021, outcome "unknown", described as "extreme fatigue"; DYSPNOEA (non-serious) with onset Aug2021, outcome "unknown", described as "easily out of breath"; VISUAL IMPAIRMENT (non-serious) with onset Aug2021, outcome "unknown", described as "vision problems"; FEELING ABNORMAL (non-serious) with onset Aug2021, outcome "unknown", described as "brain fog". Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. After the first dose, the patient had cold symptoms, a sore arm, sneezing, runny nose, cough, headache, low energy. Between the first and second dose, the patient started extreme fatigue and becoming easily out of breath. The patient also noticed some vision problems and brain fog. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Device date was reported as 23Oct2021.  Follow-up attempts are completed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nasopharyngitis, Pain in extremity, Rhinorrhoea, Sneezing
Clinical narrative: cold symptoms; sore arm; sneezing; runny nose; cough; headache; low energy; extreme fatigue; easily out of breath; vision problems; brain fog; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Aug2021 11:00 (Lot number: FA7485) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypothyroid" (unspecified if ongoing), notes: Hypothyroid. Concomitant medication(s) included: NP THYROID; VITAMIN C [ASCORBIC ACID]; VITAMIN D3; VITAMIN B12 [CYANOCOBALAMIN]; MAGNESIUM; TURMERIC [CURCUMA LONGA]. The following information was reported: NASOPHARYNGITIS (non-serious) with onset Aug2021, outcome "unknown", described as "cold symptoms"; PAIN IN EXTREMITY (non-serious) with onset Aug2021, outcome "unknown", described as "sore arm"; SNEEZING (non-serious) with onset Aug2021, outcome "unknown", described as "sneezing"; RHINORRHOEA (non-serious) with onset Aug2021, outcome "unknown", described as "runny nose"; COUGH (non-serious) with onset Aug2021, outcome "unknown", described as "cough"; HEADACHE (non-serious) with onset Aug2021, outcome "unknown", described as "headache"; ASTHENIA (non-serious) with onset Aug2021, outcome "unknown", described as "low energy"; FATIGUE (non-serious) with onset Aug2021, outcome "unknown", described as "extreme fatigue"; DYSPNOEA (non-serious) with onset Aug2021, outcome "unknown", described as "easily out of breath"; VISUAL IMPAIRMENT (non-serious) with onset Aug2021, outcome "unknown", described as "vision problems"; FEELING ABNORMAL (non-serious) with onset Aug2021, outcome "unknown", described as "brain fog". Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. After the first dose, the patient had cold symptoms, a sore arm, sneezing, runny nose, cough, headache, low energy. Between the first and second dose, the patient started extreme fatigue and becoming easily out of breath. The patient also noticed some vision problems and brain fog. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Device date was reported as 23Oct2021.  Follow-up attempts are completed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: cold symptoms; sore arm; sneezing; runny nose; cough; headache; low energy; extreme fatigue; easily out of breath; vision problems; brain fog; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Aug2021 11:00 (Lot number: FA7485) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypothyroid" (unspecified if ongoing), notes: Hypothyroid. Concomitant medication(s) included: NP THYROID; VITAMIN C [ASCORBIC ACID]; VITAMIN D3; VITAMIN B12 [CYANOCOBALAMIN]; MAGNESIUM; TURMERIC [CURCUMA LONGA]. The following information was reported: NASOPHARYNGITIS (non-serious) with onset Aug2021, outcome "unknown", described as "cold symptoms"; PAIN IN EXTREMITY (non-serious) with onset Aug2021, outcome "unknown", described as "sore arm"; SNEEZING (non-serious) with onset Aug2021, outcome "unknown", described as "sneezing"; RHINORRHOEA (non-serious) with onset Aug2021, outcome "unknown", described as "runny nose"; COUGH (non-serious) with onset Aug2021, outcome "unknown", described as "cough"; HEADACHE (non-serious) with onset Aug2021, outcome "unknown", described as "headache"; ASTHENIA (non-serious) with onset Aug2021, outcome "unknown", described as "low energy"; FATIGUE (non-serious) with onset Aug2021, outcome "unknown", described as "extreme fatigue"; DYSPNOEA (non-serious) with onset Aug2021, outcome "unknown", described as "easily out of breath"; VISUAL IMPAIRMENT (non-serious) with onset Aug2021, outcome "unknown", described as "vision problems"; FEELING ABNORMAL (non-serious) with onset Aug2021, outcome "unknown", described as "brain fog". Additional information: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. After the first dose, the patient had cold symptoms, a sore arm, sneezing, runny nose, cough, headache, low energy. Between the first and second dose, the patient started extreme fatigue and becoming easily out of breath. The patient also noticed some vision problems and brain fog. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Device date was reported as 23Oct2021.  Follow-up attempts are completed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Pain, Pyrexia
Clinical narrative: Fever; Body aches; Strong fast heart beats per minute (109-112); This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP and Physician). The reporter is the patient.  A 68-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 18Oct2021 11:00 (Lot number: ff2593) at the age of 68 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "mild heart murmur" (unspecified if ongoing), notes: many years ago, mild heart murmur on a scale of 1 to 10, a 1.; "known allergies: sulfa" (unspecified if ongoing); "known allergies: penicillin" (unspecified if ongoing). Concomitant medication(s) included: FLU, start date: 30Sep2021. Past drug history included: Aspirin, reaction(s): "Allergy: aspirin". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EWO164, Location of injection: Arm Right, Vaccine Administration Time: 10:30 AM), administration date: 14Apr2021, when the patient was 68 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: ER26B, Location of injection: Arm Right, Vaccine Administration Time: 10:30 AM), administration date: 24Mar2021, when the patient was 67 years old, for COVID-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 18Oct2021 23:30, outcome "recovered" (19Oct2021), described as "Fever"; PAIN (non-serious) with onset 18Oct2021 23:30, outcome "recovered" (19Oct2021), described as "Body aches"; HEART RATE INCREASED (non-serious) with onset 18Oct2021 23:30, outcome "recovered" (19Oct2021), described as "Strong fast heart beats per minute (109-112)". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia.  Additional information: Patient was not diagnosed with COVID-19 prior to vaccination. Patient was not tested with the Covid-19 Since the vaccination. Patient didn't receive other medications within 2 weeks of vaccination. Patient had received flu vaccination within 4 weeks of vaccination. Patient had concomitant therapy. Patient was not pregnant at vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Swelling, Tenderness
Clinical narrative: lymphadenopathy with marked pain, swelling and tenderness in left axillary and left cervical nodes.; lymphadenopathy with marked pain, swelling and tenderness in left axillary and left cervical nodes.; lymphadenopathy with marked pain, swelling and tenderness in left axillary and left cervical nodes.; lymphadenopathy with marked pain, swelling and tenderness in left axillary and left cervical nodes.; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 34 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 20Oct2021 12:00 (Lot number: FG3527) at the age of 34 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLUZONE [INFLUENZA VACCINE]), administered in arm right, administration date 20Oct2021 (Lot number: UT7356NA). Relevant medical history included: "Allergies" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Reflux" (unspecified if ongoing); "depression" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing); "Known allergies: Latex" (unspecified if ongoing); "Known allegies: Gluten" (unspecified if ongoing); "Environmental allergies" (unspecified if ongoing). Concomitant medication(s) included: ENGERIX-B, administration date 17Oct2021; HBIG; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ORAL CONTRACEPTIVE NOS; OMEPRAZOLE; TRINTELLIX; VITAMINE D. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL1284, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM, Route of Administration: Intramuscular), administration date: 07Jan2021, when the patient was 33 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EJ1685, Location of injection: Arm Left, Vaccine Administration Time: 09:00 AM, Route of Administration: Intramuscular), administration date: 17Dec2020, when the patient was 33 years old, for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious), PAIN (non-serious), SWELLING (non-serious), TENDERNESS (non-serious) all with onset 20Oct2021 16:30, outcome "not recovered" and all described as "lymphadenopathy with marked pain, swelling and tenderness in left axillary and left cervical nodes.".  Additional information: The patient received oral contraceptive (name unspecified). Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had lymphadenopathy with marked pain, swelling and tenderness in left axillary and left cervical nodes. persistent, now day 3 after injection. started 4-5 hours after third COVID vaccine in left arm. Events were persistent now. It was unknown if the patient received any treatment. The patient was administered covid-19 vaccine in a pharmacy.   Follow-up attempts are completed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dyspnoea, Pain, Pyrexia
Clinical narrative: Chills; aches; low grade fever; shortness of breath; chest pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 21Oct2021 16:00 (Lot number: EC1384) at the age of 46 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Sleep apnea" (unspecified if ongoing); "Insomnia" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing); "Adenomas on adrenal gland and pituitary gland" (unspecified if ongoing), notes: Adenomas on adrenal gland and pituitary gland; "Known allergies: Crab" (unspecified if ongoing). Concomitant medication(s) included: FLU, administration date 30Sep2021. Past drug history included: Nsaids, reaction(s): "Allergies: NSAIDS". Vaccination history included: Bnt162b2 (Dose 1, single , Batch/Lot No: EW0186, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM), administration date: 30Sep2021, when the patient was 46 years old, for COVID-19 Immunization. The following information was reported: CHILLS (non-serious) with onset 21Oct2021, outcome "not recovered", described as "Chills"; PAIN (non-serious) with onset 21Oct2021, outcome "not recovered", described as "aches"; PYREXIA (non-serious) with onset 21Oct2021, outcome "not recovered", described as "low grade fever"; DYSPNOEA (non-serious) with onset 21Oct2021, outcome "not recovered", described as "shortness of breath"; CHEST PAIN (non-serious) with onset 21Oct2021, outcome "not recovered", described as "chest pain". Therapeutic measures were not taken as a result of chills, pain, pyrexia, dyspnoea, chest pain.  Additional Information: Prior to vaccination, the patient was not diagnosed with COVID-19. The patient received Flu shot within four weeks prior to COVID-19 vaccine and other prescribed medications in two weeks. Since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Maternal exposure during pregnancy, Paraesthesia
Clinical narrative: Is pregnant: Yes, Last menstrual date: 03Jun2021, Delivery date: 11Mar2022; Left hand/ arm numbness and tingling/Beginning to radiate to feel slightly numb on left side neck as well.; Left hand/ arm numbness and tingling; This is a spontaneous report received from contactable Other HCP. The reporter is the patient.  A 37 year-old female patient (pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Oct2021 14:30 (Lot number: FF8839) at the age of 37 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Chronic gastritis" (unspecified if ongoing); "Penicillin" (unspecified if ongoing), notes: known allergies :Ibuprofen & penicillin; "if covid prior vaccination: Yes" (unspecified if ongoing), notes: if covid prior vaccination: Yes. Date of last menstrual period: 03Jun2021. The patient was 20 weeks pregnant at the time of exposure to bnt162b2. The patient was 20 weeks pregnant at the event onset. The patient is expected to deliver a baby(s) on 11Mar2022. Concomitant medication(s) included: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; PRENATAL DHA; VITAMIN D3. Past drug history included: Ibuprofen, reaction(s): "Allergy", notes: known allergies :Ibuprofen & penicillin. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: FF2589, Location of injection: Arm Left), administration date: 01Oct2021, when the patient was 37 years old, for Covid-19 Immunization. The following information was reported: MATERNAL EXPOSURE DURING PREGNANCY (non-serious), outcome "unknown", described as "Is pregnant: Yes, Last menstrual date: 03Jun2021, Delivery date: 11Mar2022"; HYPOAESTHESIA (non-serious) with onset 24Oct2021 12:00, outcome "not recovered", described as "Left hand/ arm numbness and tingling/Beginning to radiate to feel slightly numb on left side neck as well."; PARAESTHESIA (non-serious) with onset 24Oct2021 12:00, outcome "not recovered", described as "Left hand/ arm numbness and tingling". It was unknown if therapeutic measures were taken as a result of hypoaesthesia, paraesthesia.  Additional information:The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.The patient had not diagnosed with covid prior vaccination. And post vaccination, patient had not tested with covid 19. Device Date as 24Oct2021.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Dermatitis, Dry skin, Pain, Skin wrinkling
Clinical narrative: Facial dermatitis; Dry skin; increased facial wrinkles; pain; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 38 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 20Oct2021 15:30 (Lot number: FF8839) at the age of 38 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]; B COMPLEX [VITAMIN B COMPLEX]. Vaccination history included: Bnt162b2 (DOSE 1, Lot No: EJ1685, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 18Dec2020, when the patient was 37 years old, for COVID-19 Immunization; Bnt162b2 (DOSE 2), administration date: 05Jan2021, when the patient was 37 years old, for COVID-19 Immunization. The following information was reported: DERMATITIS (non-serious) with onset 21Oct2021 08:00, outcome "not recovered", described as "Facial dermatitis"; DRY SKIN (non-serious) with onset 21Oct2021 08:00, outcome "not recovered", described as "Dry skin"; SKIN WRINKLING (non-serious) with onset 21Oct2021 08:00, outcome "not recovered", described as "increased facial wrinkles"; PAIN (non-serious) with onset 21Oct2021 08:00, outcome "not recovered", described as "pain".  Additional information: The patient was not diagnosed with Covid-19, prior to vaccination and has not been tested for Covid-19 since the vaccination. The patient not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had no known allergies.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Chills; Fever; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 20Oct2021 15:15 (Lot number: EW0217) at the age of 65 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Asthma" (ongoing); "Cholesterol" (unspecified if ongoing); "blood clots in legs" (unspecified if ongoing). Concomitant medication(s) included: LIPITOR taken for blood cholesterol (ongoing); ELIQUIS taken for thrombosis (ongoing). Vaccination history included: Bnt162b2 (Dose:1, Lot:  EL3247, administered in left upper arm), administration date: 05Mar2021, when the patient was 64 years old, for COVID-19 immunization; Bnt162b2 (Dose:2, Lot: EP6955, administered in left upper arm), administration date: 24Mar2021, when the patient was 65 years old, for COVID-19 immunization, reaction(s): "Headache"; Flu vaccine (Date: 05Oct2021, it was two weeks before the Pfizer Covid Booster. ), administration date: 05Oct2021. The following information was reported: PYREXIA (non-serious) with onset 21Oct2021 10:00, outcome "recovered" (22Oct2021), described as "Fever"; CHILLS (non-serious) with onset 21Oct2021 11:00, outcome "recovered" (22Oct2021), described as "Chills".  Additional information: He got the booster dose on Wednesday 20Oct2021 and everything was fine. Then on 21Oct2021 he started to have fever and chills.  He stated the fever is all the way gone. He is starting to get better. He went to bed on 21Oct2021 and when woke up 22Oct2021 he felt better. He was unable to confirm if he has recovered completely or with lasting effects from the fever. He stated he is 80% recovered as it has not been exactly 48 hours yet. He confirmed the chills are gone. They went away the morning of 22Oct2021. He confirmed the outcome as recovered completely. The fever and chills began around 10:00 /11:00 AM Awareness date of fever and chills after the Pfizer Covid Booster- confirmed as 21Oct2021.   No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Persistent fever which reached 103.5; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Oct2021 17:00 (Lot number: 301558A) at the age of 33 years as dose 3, (booster), single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8727, Location of injection: Arm Left), administration date: 27Mar2021, when the patient was 33 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: ER8731, Location of injection: Arm Left), administration date: 17Apr2021, when the patient was 33 years old, for COVID-19 Immunization. The following information was reported: PYREXIA (non-serious), outcome "recovered", described as "Persistent fever which reached 103.5". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia.  Additional information: On an unknown date patient underwent lab tests and procedures which included body temperature: 103.5. Patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID since the vaccination. Patient had no known allergies. Patient was not hospitalized due to event.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Pyrexia
Clinical narrative: Joint pain; fever; tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 05Apr2021 (Lot number: EW0153) at the age of 49 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Peanuts" (unspecified if ongoing), notes: Known allergies: Peanuts. Concomitant medication(s) included: FLU VACCINE VII, administration date 30Sep2021. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6207, Location of injection: Left arm), administration date: 15Mar2021, when the patient was 49 years old, for COVID-19 immunization. The following information was reported: ARTHRALGIA (non-serious) with onset 24Oct2021 07:00, outcome "not recovered", described as "Joint pain"; PYREXIA (non-serious) with onset 24Oct2021 07:00, outcome "not recovered", described as "fever"; FATIGUE (non-serious) with onset 24Oct2021 07:00, outcome "not recovered", described as "tired". Therapeutic measures were not taken as a result of arthralgia, pyrexia, fatigue.  Additional information: The patient was not diagnosed with COVID-19 prior to vaccination also was not tested for COVID-19 since the vaccination.  Follow-up activities closed: Follow-up attempts are completed. No further information is expected
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: had an allergic reaction to the second dose of the 'Covid 19 vaccine'; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for covid-19 immunization. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "had an allergic reaction to the second dose of the 'Covid 19 vaccine'". Additional information: Patient recently started ramipril 5mg and her arms are hurting a great deal, which came on with onset of taking ramipril (unable to clarify if she was on brand name Altace or generic ramipril).  Her arms are sore from the shoulders down, but mostly from the elbow joints, forearms, and down to the hands and fingers.  she also had an allergic reaction to the second dose of the 'Covid 19 vaccine' (unable to clarify manufacturer name) and want to get a third dose but don't know how to go about doing that. Note: phone connection was bad and phone disconnected while customer was talking. No contact information provided at the time of disconnection. No further details available. She sounded like a female patient; age not provided. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Lymph node pain, Pain in extremity
Clinical narrative: Chills; Fever 100; Fatigue; Left Arm Pain; Left Arm Pit Lymph Node Pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An elderly female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 19Oct2021 13:30 (Lot number: FF8841) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Aortic aneurysm" (unspecified if ongoing), notes: other medical history: Aortic aneurysm; "Penicillin allergy" (unspecified if ongoing), notes: known allergies: Penicillin. Concomitant medication(s) included: LISINOPRIL; ATORVASTATIN CALCIUM; ASPIRIN [ACETYLSALICYLIC ACID]; VITAMIN D3. Past drug history included: Morphine, reaction(s): "Drug allergy", notes: known allergies: Morphine. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EM9810, Location of injection: Arm Left), administration date: 02Feb2021, for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EM6198, Location of injection: Arm Left), administration date: 01Mar2021, for COVID-19 immunization. The following information was reported: CHILLS (non-serious) with onset 20Oct2021 02:00, outcome "recovering", described as "Chills"; PYREXIA (non-serious) with onset 20Oct2021 02:00, outcome "recovering", described as "Fever 100"; FATIGUE (non-serious) with onset 20Oct2021 02:00, outcome "recovering", described as "Fatigue"; PAIN IN EXTREMITY (non-serious) with onset 20Oct2021 02:00, outcome "recovering", described as "Left Arm Pain"; LYMPH NODE PAIN (non-serious) with onset 20Oct2021 02:00, outcome "recovering", described as "Left Arm Pit Lymph Node Pain". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of chills, pyrexia, fatigue, pain in extremity, lymph node pain.  Additional information: Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.